Cain McClary MD
Founder & Managing Partner at KdT Ventures
Cain McClary, MD is the founder and Managing Partner of KdT Ventures a seed stage venture capital firm focused at the intersection of computation and biology across the verticals of chemicals, agriculture, and medicine.
Over the past 10 years, Cain has been at the forefront of the intersection between technology and science/medicine. In addition to personal investments in this space, including companies like Zymergen, Firefly Bioworks (Acquired by AbCam), Concert Genetics, and PathAI, Cain has been an active advisor to both companies and institutional investors (i.e. 8VC, Lux Capital, Andreessen Horowitz, Innovation Endeavors, NueCura Partners, Cleargenes, HealthSpek, etc…), with contributions ranging from scientific thesis development all the way to monetization of product/company.
Additionally, Cain is involved in entrepreneurship and finance advisory at both the local and national levels as well as on the faculty at Stanford University and the Tulane University School of Medicine.